Log In
Print
BCIQ
Print
Print this Print this
 

I-131-MIP-1466

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionSmall molecule radiopharmaceutical targeting prostate-specific antigen (KLK3; PSA)
Molecular Target Prostate-specific antigen (KLK3) (PSA)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today